Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART

Clinical trial NCT02225665 · COMPLETED

Trial details

NCT number: NCT02225665
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)

Start date: 2014-08-01
Primary completion: 2018-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.